Suppr超能文献

子宫体非子宫内膜样腺癌:特定组织学亚型综述

Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes.

作者信息

Mendivil Alberto, Schuler Kevin M, Gehrig Paola A

机构信息

Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

Cancer Control. 2009 Jan;16(1):46-52. doi: 10.1177/107327480901600107.

Abstract

BACKGROUND

Understanding the etiology, presentation, evaluation, and management of selected non-endometrioid endometrial adenocarcinomas of the uterine corpus is needed to define optimal treatment regimens.

METHODS

The pathology and treatment of selected non-endometrioid endometrial adenocarcinomas of the uterus are reviewed and summarized.

RESULTS

The most common non-endometrioid histology is papillary serous (10%), followed by clear cell (2% to 4%), mucinous (0.6% to 5%), and squamous cell (0.1% to 0.5%). Some non-endometrioid endometrial carcinomas behave more aggressively than the endometrioid cancers such that even women with clinical stage I disease often have extrauterine metastasis at the time of surgical evaluation. Therefore, when technically and medically feasible, comprehensive surgical staging is helpful for women with non-endometrioid endometrial cancer histology. Comprehensive surgical staging includes hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and cytological evaluation of the abdominal cavity. While whole abdominal radiotherapy has a limited role in early-stage uterine papillary serous carcinoma (UPSC) and clear cell carcinoma (CC), there may be a role for postoperative chemotherapy and volume-directed radiotherapy in both early-stage UPSC and CC. In the setting of optimally debulked advanced-stage disease, a combination of radiation and chemotherapy may be indicated. In the setting of recurrent disease or in women with residual disease after surgery, a platinum-based regimen or enrollment in a clinical trial is recommended.

CONCLUSIONS

UPSC and CC are managed similarly since sufficient data to separate treatment recommendations are lacking. Because both histologies are associated with a high rate of recurrence, adjuvant therapy is recommended even in women with early-stage disease. The remaining cell types should be treated similar to endometrioid or other low-grade histologies.

摘要

背景

为确定最佳治疗方案,需要了解子宫体某些非子宫内膜样子宫内膜腺癌的病因、表现、评估及管理方法。

方法

对子宫某些非子宫内膜样子宫内膜腺癌的病理及治疗进行回顾和总结。

结果

最常见的非子宫内膜样组织学类型为乳头状浆液性(10%),其次是透明细胞(2%至4%)、黏液性(0.6%至5%)和鳞状细胞(0.1%至0.5%)。一些非子宫内膜样子宫内膜癌的行为比子宫内膜样癌更具侵袭性,以至于即使是临床I期疾病的女性在手术评估时也常发生子宫外转移。因此,在技术和医学可行的情况下,全面的手术分期对非子宫内膜样组织学类型的子宫内膜癌女性有益。全面的手术分期包括子宫切除术、双侧输卵管卵巢切除术、盆腔和腹主动脉旁淋巴结切除术以及腹腔细胞学评估。虽然全腹放疗在早期子宫乳头状浆液性癌(UPSC)和透明细胞癌(CC)中的作用有限,但术后化疗和靶体积放疗在早期UPSC和CC中可能都有作用。在晚期疾病达到最佳减瘤的情况下,可能需要放疗和化疗联合应用。在复发性疾病或手术后有残留疾病的女性中,建议采用铂类方案或参加临床试验。

结论

由于缺乏足够的数据来区分治疗建议,UPSC和CC的管理方式相似。因为这两种组织学类型都与高复发率相关,所以即使是早期疾病的女性也建议进行辅助治疗。其余细胞类型的治疗应类似于子宫内膜样或其他低级别组织学类型。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验